Acorda Therapeutics Inc (ACORQ)
0.85
0.00 (0.00%)
USD |
OTCM |
May 02, 15:59
Acorda Therapeutics Free Cash Flow (Quarterly): -3.062M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.062M |
| September 30, 2023 | 7.388M |
| June 30, 2023 | -11.56M |
| March 31, 2023 | -7.018M |
| December 31, 2022 | 9.189M |
| September 30, 2022 | -1.989M |
| June 30, 2022 | -14.58M |
| March 31, 2022 | -13.68M |
| December 31, 2021 | 3.239M |
| September 30, 2021 | -9.012M |
| June 30, 2021 | -8.824M |
| March 31, 2021 | -26.94M |
| December 31, 2020 | 1.132M |
| September 30, 2020 | -2.757M |
| June 30, 2020 | -22.75M |
| March 31, 2020 | -41.02M |
| December 31, 2019 | -25.44M |
| September 30, 2019 | -43.50M |
| June 30, 2019 | -47.51M |
| March 31, 2019 | -102.15M |
| December 31, 2018 | -23.33M |
| September 30, 2018 | 66.20M |
| June 30, 2018 | 50.12M |
| March 31, 2018 | 23.89M |
| December 31, 2017 | 56.82M |
| Date | Value |
|---|---|
| September 30, 2017 | 50.05M |
| June 30, 2017 | 7.154M |
| March 31, 2017 | -31.27M |
| December 31, 2016 | 26.46M |
| September 30, 2016 | 10.50M |
| June 30, 2016 | -286.10M |
| March 31, 2016 | 5.254M |
| December 31, 2015 | 21.06M |
| September 30, 2015 | 20.98M |
| June 30, 2015 | 1.344M |
| March 31, 2015 | -11.97M |
| December 31, 2014 | -466.81M |
| September 30, 2014 | 37.19M |
| June 30, 2014 | 18.17M |
| March 31, 2014 | 2.165M |
| December 31, 2013 | 18.21M |
| September 30, 2013 | 10.15M |
| June 30, 2013 | 5.617M |
| March 31, 2013 | -9.356M |
| December 31, 2012 | 14.20M |
| September 30, 2012 | 16.34M |
| June 30, 2012 | 8.755M |
| March 31, 2012 | -0.748M |
| December 31, 2011 | 29.28M |
| September 30, 2011 | 42.36M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-47.51M
Minimum
Jun 2019
9.189M
Maximum
Dec 2022
-13.62M
Average
-9.012M
Median
Sep 2021
Free Cash Flow (Quarterly) Benchmarks
| BioSig Technologies Inc | -2.946M |
| Verve Therapeutics Inc | -42.86M |
| Spectral AI Inc | -5.338M |
| AIM ImmunoTech Inc | -9.956M |
| Protalix BioTherapeutics Inc | 3.345M |